Evolent Health (EVH) Net Income towards Common Stockholders (2016 - 2025)
Evolent Health (EVH) has 11 years of Net Income towards Common Stockholders data on record, last reported at -$429.2 million in Q4 2025.
- For Q4 2025, Net Income towards Common Stockholders fell 1300.99% year-over-year to -$429.2 million; the TTM value through Dec 2025 reached -$579.5 million, down 519.93%, while the annual FY2025 figure was -$534.5 million, 1579.29% down from the prior year.
- Net Income towards Common Stockholders reached -$429.2 million in Q4 2025 per EVH's latest filing, down from -$26.9 million in the prior quarter.
- Across five years, Net Income towards Common Stockholders topped out at $2.1 million in Q3 2022 and bottomed at -$429.2 million in Q4 2025.
- Average Net Income towards Common Stockholders over 5 years is -$43.6 million, with a median of -$25.7 million recorded in 2023.
- Peak YoY movement for Net Income towards Common Stockholders: skyrocketed 116.28% in 2022, then tumbled 1663.64% in 2023.
- A 5-year view of Net Income towards Common Stockholders shows it stood at -$5.6 million in 2021, then plummeted by 100.97% to -$11.3 million in 2022, then tumbled by 264.75% to -$41.4 million in 2023, then grew by 25.99% to -$30.6 million in 2024, then tumbled by 1300.99% to -$429.2 million in 2025.
- Per Business Quant database, its latest 3 readings for Net Income towards Common Stockholders were -$429.2 million in Q4 2025, -$26.9 million in Q3 2025, and -$51.1 million in Q2 2025.